Tropical Animal Health and Production

, Volume 38, Issue 1, pp 1–7

The in vitro effect of six antimicrobials against Mycoplasma putrefaciens, Mycoplasma mycoides subsp. mycoides LC and Mycoplasma capricolum subsp. capricolum isolated from sheep and goats in jordan

  • W. Al-Momani
  • E. Abu-Basha
  • R. D. Ayling
  • R. A. J. Nicholas
  • S. Janakat
Original Article
  • 136 Downloads

Abstract

Respiratory disease in sheep and goats is a major problem in Jordan and is often associated with Mycoplasma species. Without effective vaccines, control is mainly by chemotherapy, but the uncontrolled use of antimicrobials has led to concerns about the potential development of antimicrobial resistance. The in vitro effect of chloramphenicol, florfenicol, enrofloxacin, tylosin, erythromycin and oxytetracycline was determined against 32 isolates of Mycoplasma species—M. mycoides subsp. mycoides LC (6), M. capricolum subsp. capricolum (8) and M. putrefaciens (18), all isolated from either nasal swabs or milk, from sheep and goats in different regions of Jordan. The antimicrobial susceptibility showed some Mycoplasma species-specific differences, with M. capricolum subsp. capricolum being more susceptible to tylosin and erythromycin. Chloramphenicol and florfenicol were the least effective for all three Mycoplasma species. No trends or significant differences in antimicrobial susceptibilities were observed between sheep and goat isolates, between milk or nasal swab isolates, or between isolates from different regions of Jordan. Some isolates of M. capricolum subsp. capricolum and M. putrefaciens showed higher MIC levels with oxytetracycline, as did two isolates of M. mycoides subsp. mycoides LC with tylosin, possibly indicating signs of development of antimicrobial resistance.

Keyword

Antimicrobial susceptibility Goat Jordan Mycoplasma Sheep 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abo-Shehada, M.N., Arab, B., Mukbel, R., Williams, D. and Torgerson, P.R., 2002. Age and seasonal variations in the prevalence of Oestrus ovis larvae among sheep in northern Jordan. Preventive Veterinary Medicine, 47, 205–212Google Scholar
  2. Al-Momani, W., Halablab, M.A., Abo-Shehada, M.N., McAuliffe, L., Miles, K. and Nicholas, R.A.J., 2005. Isolation and characterisation of small ruminant mycoplasmas in Jordan using denaturing gradient gel electrophoresis (DGGE) and specific PCR. Small Ruminant Research (in press)Google Scholar
  3. Anon, 1995. The Annual Report, (Ministry of Agriculture, Jordan)Google Scholar
  4. Ayling, R.D., Baker, S.E., Nicholas, R.A.J., Peek, M.L. and Simon, A.J., 2000. Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against Mycoplasma mycoides subsp. mycoides small colony type. Veterinary Record, 146, 243–245PubMedGoogle Scholar
  5. Bashiruddin, J.B., Taylor, T.K. and Gould, A.R., 1994. A PCR based test for the specific identification of M. mycoides subspecies mycoides SC. Journal of Veteterinary Diagnostics and Investigations, 6, 428–434Google Scholar
  6. Bébéar, C., 1996. Introductory remarks. In: J.G. Tully and S. Razin (eds), Molecular and Diagnostic Procedures, Vol. II, (Academic Press, London), 181–183Google Scholar
  7. Hannan, P.C.T., 2000. Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary Mycoplasma species. Veterinary Research, 31, 373–395CrossRefPubMedGoogle Scholar
  8. Loria, G.R., Sammartino, C., Nicholas, R.A.J. and Ayling, R.D., 2003. In vitro susceptibilities of field isolates of Mycoplasma agalactiae to oxytetracycline, tylosine, enrofloxacin, spiramycin and lincomycine-spectinimycine. Research in Veterinary Sciences, 75, 3–7Google Scholar
  9. Madanat, A., Zendulková, D., Lány, P., Pospišil, Z. and Cihal, P., 2002. Prevalence of Mycoplasma agalactiae antibodies in Czech and Jordanian herds of small ruminants. Acta Veterinaria Bruno, 71, 37–44Google Scholar
  10. McAuliffe, L., Ellis, R., Ayling, R.D. and Nicholas, R.A.J., 2003. Differentiation of Mycoplasma species by 16S ribosomal DNA PCR and denaturing gradient gel electrophoresis fingerprinting. Journal of Clinical Microbiology, 41, 4844–4847CrossRefPubMedGoogle Scholar
  11. Nicholas, R., Bashiruddin, J., Ayling, R. and Miles, R.J., 2000. Contagious bovine pleuropneumonia: a review of recent developments. Veterinary Bulletin, 70(8), 827–838Google Scholar
  12. Poveda, J.B. and Nicholas, R.A.J., 1998. Serological identification by growth inhibition and metabolic inhibition tests. In: R.J. Miles and R.A.J. Nicholas (eds), Mycoplasma Protocols, (Humana Press, Totowa, NJ), 105–113Google Scholar
  13. Puglisi, J.D., Blanchard, S.C., Dahlquist, K.D., Eason, R.G., Fourmy, D., Lynch, S.R., Recht, M.I. and Yoshizawa, S., 2000. Aminoglycoside antibioticsand decoding. In: R.A. Carret, S.R. Douthwaite, A. Liljas, A.T. Matheson, P.B. Moore and H. F. Noller (eds), The Ribosomes Structure, Functions, Antibiotics and Cellular Interactions. (American Society for Microbiology, Washington, DC), 419–430Google Scholar
  14. Roberts, M.C., 1992. Antibiotic resistance. In: J. Maniloff, R.N. McElhaney, L.R. Finch and J.B. Baseman (eds), Mycoplasmas Molecular Biology and Pathogenesis, (American Society for Microbiology, Washington, DC), 513–523Google Scholar
  15. Taylor-Robinson, D. and Bébéar, C., 1997. Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infection. Journal of Antimicrobial Chemotherapy, 40, 622–630CrossRefPubMedGoogle Scholar
  16. Woods, G.L. and Washington, J.A., 1995. Antibacterial susceptibility tests, dilution and disk diffusion methods. In: Manual of Clinical Microbiology, (American Society for Microbiology, Washington, DC), 1327–1341Google Scholar
  17. Yamaguchi, T., Hirakata, Y., Izumikawa, K., Yoshitsugu Miyazaki, Y., Maesaki, S., Tomono, K., Yamada, Y., Kamihira, S. and Kohno, S., 2000. In vitro activity of telithromycin (HMR3647), a new ketolide, against clinical isolates of Mycoplasma pneumoniae in Japan. Antimicrobial Agents and Chemotherapy, 44, 1381–1382.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  • W. Al-Momani
    • 1
  • E. Abu-Basha
    • 4
  • R. D. Ayling
    • 2
  • R. A. J. Nicholas
    • 2
  • S. Janakat
    • 3
  1. 1.Department of Life SciencesKings College LondonLondon
  2. 2.Mycoplasma Group, Statutory and Exotic Bacterial Diseases DepartmentVeterinary Laboratories Agency (Weybridge)SurreyUK
  3. 3.Division of Nutrition and Food TechnologyJordan University of Science and TechnologyIrbidJordan
  4. 4.Department of Basic Medical Veterinary SciencesJordan University of Science and TechnologyIrbidJordan

Personalised recommendations